Search Page

1

Cite

Share

Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma.

Dong R, Yang R, Zhan Y, Lai HD, Ye CJ, Yao XY, Luo WQ, Cheng XM, Miao JJ, Wang JF, Liu BH, Liu XQ, Xie LL, Li Y, Zhang M, Chen L, Song WC, Qian W, Gao WQ, Tang YH, Shen CY, Jiang W, Chen G, Yao W, Dong KR, Xiao XM, Zheng S, Li K, Wang J. Dong R, et al. Cancer Cell. 2020 Nov 9;38(5):716-733.e6. doi: 10.1016/j.ccell.2020.08.014. Epub 2020 Sep 17. Cancer Cell. 2020. PMID: 32946775 Free article.

Cite

Share

2

Cite

Share

PROTAC: A promising technology for cancer treatment.

Zhou X, Dong R, Zhang JY, Zheng X, Sun LP. Zhou X, et al. Among authors: dong r. Eur J Med Chem. 2020 Oct 1;203:112539. doi: 10.1016/j.ejmech.2020.112539. Epub 2020 Jul 15. Eur J Med Chem. 2020. PMID: 32698111 Review.

Cite

Share

3

Cite

Share

Berberine in the treatment of ulcerative colitis: A possible pathway through Tuft cells.

Xiong X, Cheng Z, Wu F, Hu M, Liu Z, Dong R, Chen G. Xiong X, et al. Among authors: dong r. Biomed Pharmacother. 2021 Feb;134:111129. doi: 10.1016/j.biopha.2020.111129. Epub 2020 Dec 24. Biomed Pharmacother. 2021. PMID: 33348308 Free article. Review.

Cite

Share

4

Cite

Share

Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery.

Luo N, Li J, Chen Y, Xu Y, Wei Y, Lu J, Dong R. Luo N, et al. Among authors: dong r. Drug Deliv. 2021 Dec;28(1):10-18. doi: 10.1080/10717544.2020.1850917. Drug Deliv. 2021. PMID: 33336604 Free PMC article.

Cite

Share

5

Cite

Share

EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research.

Dong RF, Zhu ML, Liu MM, Xu YT, Yuan LL, Bian J, Xia YZ, Kong LY. Dong RF, et al. Pharmacol Res. 2021 May;167:105583. doi: 10.1016/j.phrs.2021.105583. Epub 2021 Mar 26. Pharmacol Res. 2021. PMID: 33775864 Review.

Cite

Share

6

Cite

Share

[Retracted] Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells.

Yang Q, Zhang S, Kang M, Dong R, Zhao J. Yang Q, et al. Among authors: dong r. Oncol Rep. 2021 Sep;46(3):193. doi: 10.3892/or.2021.8144. Epub 2021 Jul 19. Oncol Rep. 2021. PMID: 34278510 Free PMC article.

Cite

Share

7

Cite

Share

Hereditäre Ichthyose und Pilzinfektion: aktuelle Daten zu Pathogenese und Behandlungsstrategien.

Miao H, Dong R, Zhang S, Yang L, Liu Y, Wang T. Miao H, et al. Among authors: dong r. J Dtsch Dermatol Ges. 2021 Mar;19(3):341-351. doi: 10.1111/ddg.14389_g. J Dtsch Dermatol Ges. 2021. PMID: 33709589 Review. German.

Cite

Share

8

Cite

Share

Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B-related hepatocellular carcinoma.

Chai X, Guo J, Dong R, Yang X, Deng C, Wei C, Xu J, Han W, Lu J, Gao C, Gao D, Huang C, Ke A, Li S, Li H, Tian Y, Gu Z, Liu S, Liu H, Chen Q, Liu F, Zhou J, Fan J, Shi G, Wu F, Cai J. Chai X, et al. Among authors: dong r. Clin Transl Med. 2021 Mar;11(3):e313. doi: 10.1002/ctm2.313. Clin Transl Med. 2021. PMID: 33783990 Free PMC article.

Cite

Share

9

Cite

Share

First-in-Human Phase I Study of Envafolimab, a Novel Subcutaneous Single-Domain Anti-PD-L1 Antibody, in Patients with Advanced Solid Tumors.

Papadopoulos KP, Harb W, Peer CJ, Hua Q, Xu S, Lu H, Lu N, He Y, Xu T, Dong R, Gong J, Liu D. Papadopoulos KP, et al. Among authors: dong r. Oncologist. 2021 Sep;26(9):e1514-e1525. doi: 10.1002/onco.13817. Epub 2021 May 27. Oncologist. 2021. PMID: 33973293 Free PMC article. Clinical Trial.

Cite

Share

10

Cite

Share

[Retracted] Polyphenol‑rich extract of Saliva chinensis exhibits anticancer activity in different cancer cell lines, and induces cell cycle arrest at the G0/G1‑phase, apoptosis and loss of mitochondrial membrane potential in pancreatic cancer cells.

Zhao Q, Huo XC, Sun FD, Dong RQ. Zhao Q, et al. Among authors: dong rq. Mol Med Rep. 2021 Jun;23(6):462. doi: 10.3892/mmr.2021.12101. Epub 2021 Apr 21. Mol Med Rep. 2021. PMID: 33880580 Free PMC article.

Cite

Share